Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teresa Calimeri

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
British Journal of Haematology|May 13, 2020
Prevention of CNS relapse in diffuse large B-cell lymphoma: common sense prevails where science failsTeresa Calimeri, Andrés J M Ferreri
British Journal of Haematology|February 2, 2017
m-TOR inhibitors and their potential role in haematological malignanciesTeresa Calimeri, Andrés J M Ferreri
British Journal of Haematology|September 14, 2024
CNS prophylaxis in large B-cell lymphomas: A balance with three pansTeresa Calimeri, Andrés J M Ferreri
The Lancet. Haematology|June 4, 2026
Beyond biomarkers: tissue still mattersTeresa Calimeri, Andrés J M Ferreri
Clinical Lymphoma, Myeloma & Leukemia|May 16, 2026
SOHO State of the Art Updates and Next Questions | Management of Primary Central Nervous System LymphomaPaolo Fiore, Teresa Calimeri, Andrés J M Ferreri
Expert Review of Neurotherapeutics|April 11, 2018
Challenges and prospects in the diagnosis and treatment of primary central nervous system lymphomaGiovanni Citterio, Teresa Calimeri, Andrés J M Ferreri
Pharmaceutics|July 27, 2022
Targeting the Blood-Brain Tumor Barrier with Tumor Necrosis Factor-αAngelo Corti, Teresa Calimeri, Flavio Curnis, et al.
Current Opinion in Oncology|August 8, 2023
New hopes in relapsed refractory primary central nervous system lymphomaTeresa Calimeri, Carolina Steidl, Paolo Fiore, et al.
Expert Opinion on Therapeutic Targets|October 4, 2021
Implications of recent molecular achievements in early diagnosis and precision treatments for primary CNS lymphomaTeresa Calimeri, Sara Steffanoni, Marco Foppoli, et al.
Expert Review of Hematology|December 14, 2021
A narrative review of consolidation strategies for young and fit patients with newly-diagnosed primary central nervous system lymphomaSara Steffanoni, Teresa Calimeri, Nicoletta Anzalone, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
British Journal of Haematology|May 13, 2020
Prevention of CNS relapse in diffuse large B-cell lymphoma: common sense prevails where science failsTeresa Calimeri, Andrés J M Ferreri
British Journal of Haematology|February 2, 2017
m-TOR inhibitors and their potential role in haematological malignanciesTeresa Calimeri, Andrés J M Ferreri
British Journal of Haematology|September 14, 2024
CNS prophylaxis in large B-cell lymphomas: A balance with three pansTeresa Calimeri, Andrés J M Ferreri
The Lancet. Haematology|June 4, 2026
Beyond biomarkers: tissue still mattersTeresa Calimeri, Andrés J M Ferreri
Clinical Lymphoma, Myeloma & Leukemia|May 16, 2026
SOHO State of the Art Updates and Next Questions | Management of Primary Central Nervous System LymphomaPaolo Fiore, Teresa Calimeri, Andrés J M Ferreri
Expert Review of Neurotherapeutics|April 11, 2018
Challenges and prospects in the diagnosis and treatment of primary central nervous system lymphomaGiovanni Citterio, Teresa Calimeri, Andrés J M Ferreri
Pharmaceutics|July 27, 2022
Targeting the Blood-Brain Tumor Barrier with Tumor Necrosis Factor-αAngelo Corti, Teresa Calimeri, Flavio Curnis, et al.
Current Opinion in Oncology|August 8, 2023
New hopes in relapsed refractory primary central nervous system lymphomaTeresa Calimeri, Carolina Steidl, Paolo Fiore, et al.
Expert Opinion on Therapeutic Targets|October 4, 2021
Implications of recent molecular achievements in early diagnosis and precision treatments for primary CNS lymphomaTeresa Calimeri, Sara Steffanoni, Marco Foppoli, et al.
Expert Review of Hematology|December 14, 2021
A narrative review of consolidation strategies for young and fit patients with newly-diagnosed primary central nervous system lymphomaSara Steffanoni, Teresa Calimeri, Nicoletta Anzalone, et al.
Pageof 6